Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fumidil B
1. 23110-15-8
2. Fugillin
3. Fumidil
4. Amebacilin
5. Fumagilline
6. Fumagillinum
7. Fumagilina
8. (-)-fumagillin
9. Zgn-201
10. Amebacillin
11. Fugilin
12. Chembl32838
13. 2,4,6,8-decatetraenedioic Acid, 4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2,5)oct-6-yl Ester
14. Fumagillin Dch
15. Chebi:48635
16. Nsc-9168
17. 7ow73204u1
18. Dsstox_cid_20736
19. Dsstox_rid_79580
20. Dsstox_gsid_40736
21. (2e,4e,6e,8e)-10-({(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]oct-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic Acid
22. Fumagillina
23. Flisint
24. (2e,4e,6e,8e)-10-(((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl)oxy)-10-oxodeca-2,4,6,8-tetraeno
25. Cas-23110-15-8
26. Fumagillina [dcit]
27. U 5762
28. Fumagilina [inn-spanish]
29. Fumagilline [inn-french]
30. Fumagillinum [inn-latin]
31. Nsc9168
32. Fumagillin [inn:ban:dcf]
33. Ccris 9025
34. Unii-7ow73204u1
35. Ncgc00163699-01
36. H-3
37. Nsc 9168
38. Einecs 245-433-8
39. Fumagillin [mi]
40. Fumagillin [inn]
41. Fumagillin [mart.]
42. Schembl8130
43. Fumagillin [who-dd]
44. Dtxsid7040736
45. Schembl15263952
46. (2e,4e,6e,8e)-mono[(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] 2,4,6,8-decatetraenedioic Acid Ester
47. Ex-a2890
48. Hy-b0751
49. Zinc4098264
50. Tox21_112066
51. Tox21_302410
52. Bdbm50113436
53. S7784
54. Akos024456768
55. Db02640
56. Lmpr0103060003
57. Ncgc00163699-02
58. Ncgc00163699-07
59. Ncgc00255568-01
60. Ac-35866
61. Bs-16576
62. Sr-90144
63. D81922
64. Q120199
65. (2e,4e,6e,8e)-10-(((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl)oxy)-10-oxodeca-2,4,6,8-tetraenoic Acid
66. 127913-45-5
67. 2,4,6,8-decatetraenedioic Acid, 1-((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (2e,4e,6e,8e)-
68. 2,4,6,8-decatetraenedioic Acid, Mono((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (2e,4e,6e,8e)-
69. 2,4,6,8-decatetraenedioic Acid, Mono(4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2.5)oct-6-yl) Ester
70. 2,4,6,8-decatetraenedioic Acid, Mono(4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2.5)oct-6-yl) Ester (van)
71. 2,4,6,8-decatetraenedioic Acid, Mono(5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (3r- (3.alpha.,4.alpha.(2r*,3r*),5.beta.,6.beta.(2e,4e,6e,8e)))-
72. 2,4,6,8-decatetraenedioic Acid, Mono(5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (3r-(3alp
73. 2,4,6,8-decatetraenedioic Acid, Mono[(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methyl-2-buten-1-yl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] Ester, (2e,4e,6e,8e)-
74. Antibiotic Obtained From Cultures Of Aspergillus Fumigatus, Or The Same Substance Produced By Any Other Means
Molecular Weight | 458.5 g/mol |
---|---|
Molecular Formula | C26H34O7 |
XLogP3 | 4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 458.23045342 g/mol |
Monoisotopic Mass | 458.23045342 g/mol |
Topological Polar Surface Area | 97.9 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 879 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Angiogenesis Inhibitors
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AX - Other agents against amoebiasis and other protozoal diseases
P01AX10 - Fumagillin
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?